{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:48:48Z","timestamp":1789174128565,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNRR MCNT2- 2023-12377846 (GUMBLE Study)"],"award-info":[{"award-number":["PNRR MCNT2- 2023-12377846 (GUMBLE Study)"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s40120-025-00860-5","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T14:58:18Z","timestamp":1763650698000},"page":"213-235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lacosamide is Associated with a Higher Treatment Persistence at 12\u00a0Months than Brivaracetam and Perampanel Despite Similar Efficacy"],"prefix":"10.1007","volume":"15","author":[{"given":"Roberta","family":"Roberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Politi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Anzellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Belcastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Boero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Canafoglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"D\u2019Aniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Dainese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"De Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Di Gennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Di Giacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo C.","family":"DiFrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedele","family":"Dono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Falcicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Ferlazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Foschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gambardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Labate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"La Neve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Lattanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Leggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Maschio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Mattioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annacarmen","family":"Nilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Felicia","family":"Operto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Pascarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Pauletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Renna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gionata","family":"Strigaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"COMPARE Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Andreone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Arnaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Badioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Buttarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cagnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cantello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Danieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Deleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fortunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Lazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Maialetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Biagio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Osanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Pascarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano L","family":"Sensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam Tabaee","family":"Damavandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Tinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Verriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pio","family":"Zoleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-8123","authenticated-orcid":false,"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Di Gennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"860_CR1","doi-asserted-by":"publisher","unstructured":"Beghi E. The epidemiology of epilepsy. Neuroepidemiology. 2020:54(2):185\u201391. https:\/\/doi.org\/10.1159\/000503831.","DOI":"10.1159\/000503831"},{"key":"860_CR2","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/epi.17241","volume":"63","author":"N Specchio","year":"2022","unstructured":"Specchio N, Wirrell EC, Scheffer IE, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63:1398\u2013442. https:\/\/doi.org\/10.1111\/epi.17241.","journal-title":"Epilepsia"},{"key":"860_CR3","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/epi.17240","volume":"63","author":"K Riney","year":"2022","unstructured":"Riney K, Bogacz A, Somerville E, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63:1443\u201374. https:\/\/doi.org\/10.1111\/epi.17240.","journal-title":"Epilepsia"},{"key":"860_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475\u201382. https:\/\/doi.org\/10.1111\/epi.12550.","journal-title":"Epilepsia"},{"key":"860_CR5","doi-asserted-by":"publisher","unstructured":"D\u2019Onofrio G, Roberti R, Riva A, et al. Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric population. Neurotherapeutics. 2024:21(3):e00344. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00344.","DOI":"10.1016\/j.neurot.2024.e00344"},{"key":"860_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2025.2510302","author":"R Roberti","year":"2025","unstructured":"Roberti R, Riva A, Striano P, Russo E. Drug\u2013drug interaction between anti-seizure medications in Dravet syndrome and Lennox\u2013Gastaut syndrome. Expert Opin Drug Metab Toxicol. 2025. https:\/\/doi.org\/10.1080\/17425255.2025.2510302.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"860_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/FNEUR.2021.674483","author":"A Fattorusso","year":"2021","unstructured":"Fattorusso A, Matricardi S, Mencaroni E, et al. The pharmacoresistant epilepsy: an overview on existant and new emerging therapies. Front Neurol. 2021. https:\/\/doi.org\/10.3389\/FNEUR.2021.674483.","journal-title":"Front Neurol"},{"key":"860_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/epi.12294","volume":"54","author":"JA French","year":"2013","unstructured":"French JA, White HS, Klitgaard H, et al. Development of new treatment approaches for epilepsy: unmet needs and opportunities. Epilepsia. 2013;54:3\u201312. https:\/\/doi.org\/10.1111\/epi.12294.","journal-title":"Epilepsia"},{"key":"860_CR9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/17425255.2020.18062360","volume":"16","author":"R Roberti","year":"2020","unstructured":"Roberti R, Palleria C, Nesci V, et al. Pharmacokinetic considerations about antiseizure medications in the elderly. Expert Opin Drug Metab Toxicol. 2020;16:983\u201395. https:\/\/doi.org\/10.1080\/17425255.2020.18062360.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"860_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","volume":"75","author":"Z Chen","year":"2018","unstructured":"Chen Z, Brodie MJ, Liew D, Kwan P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs a 30-year longitudinal cohort study. JAMA Neurol. 2018;75:279\u201386. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3949.","journal-title":"JAMA Neurol"},{"key":"860_CR11","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069\u201377. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02397.x.","journal-title":"Epilepsia]"},{"key":"860_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40265-021-01661-4","volume":"82","author":"S Lattanzi","year":"2022","unstructured":"Lattanzi S, Trinka E, Zaccara G, et al. Third-generation antiseizure medications for adjunctive treatment of focal-onset seizures in adults: a systematic review and network meta-analysis. Drugs Adis. 2022;82:199\u2013218. https:\/\/doi.org\/10.1007\/s40265-021-01661-4.","journal-title":"Drugs Adis"},{"key":"860_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210231","author":"S Misra","year":"2025","unstructured":"Misra S, Wang S, Quinn TJ, et al. Antiseizure medications in poststroke seizures: a systematic review and network meta-analysis. Neurology. 2025. https:\/\/doi.org\/10.1212\/WNL.0000000000210231.","journal-title":"Neurology"},{"key":"860_CR14","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1002\/epi4.12997","volume":"9","author":"H Zhang","year":"2024","unstructured":"Zhang H, Ou Z, Zhang E,et al. Efficacy and safety of add-on antiseizure medications for focal epilepsy: a network meta-analysis. Epilepsia Open. 2024;9:1550\u201364. https:\/\/doi.org\/10.1002\/epi4.12997.","journal-title":"Epilepsia Open"},{"key":"860_CR15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s40263-023-01029-0","volume":"37","author":"H Wang","year":"2023","unstructured":"Wang H, Wang H, Liu Y, et al. Efficacy and safety of five broad-spectrum antiseizure medications for adjunctive treatment of refractory epilepsy: a systematic review and network meta-analysis. CNS Drugs. 2023;37:883\u2013913. https:\/\/doi.org\/10.1007\/s40263-023-01029-0.","journal-title":"CNS Drugs"},{"key":"860_CR16","doi-asserted-by":"publisher","first-page":"1500475","DOI":"10.3389\/fphar.2025.1500475","volume":"16","author":"N-J Deng","year":"2025","unstructured":"Deng N-J, Li X-Y, Zhang Z-X, et al. Effectiveness and safety of single anti-seizure medication as adjunctive therapy for drug-resistant focal epilepsy based on network meta-analysis. Front Pharmacol]. 2025;16:1500475. https:\/\/doi.org\/10.3389\/fphar.2025.1500475.","journal-title":"Front Pharmacol"},{"key":"860_CR17","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/epi.17843","volume":"65","author":"R Roberti","year":"2024","unstructured":"Roberti R, Di Gennaro G, Anzellotti F, et al. A real-world comparison among third-generation antiseizure medications: results from the COMPARE study. Epilepsia. 2024;65:456\u201372. https:\/\/doi.org\/10.1111\/epi.17843.","journal-title":"Epilepsia"},{"key":"860_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/15357597241232877","volume":"24","author":"I Karakis","year":"2024","unstructured":"Karakis I. Mirror, mirror on the wall, who\u2019s the fairest third generation anti-seizure medication of all? Epilepsy Curr. 2024;24:165\u20137. https:\/\/doi.org\/10.1177\/15357597241232877.","journal-title":"Epilepsy Curr"},{"key":"860_CR19","unstructured":"World Health Organization. Defined daily dose (DDD). 2024. https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/about-ddd. Accessed July 4, 2025."},{"key":"860_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12182","author":"MM Garrido","year":"2014","unstructured":"Garrido MM, Kelley AS, Paris J, et al. Methods for constructing and assessing propensity scores. Health Serv Res. 2014. https:\/\/doi.org\/10.1111\/1475-6773.12182.","journal-title":"Health Serv Res"},{"key":"860_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2014.05.014","author":"MM Garrido","year":"2014","unstructured":"Garrido MM. Propensity scores: a practical method for assessing treatment effects in pain and symptom management research. J Pain Symptom Manag. 2014. https:\/\/doi.org\/10.1016\/j.jpainsymman.2014.05.014.","journal-title":"J Pain Symptom Manag"},{"key":"860_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab158","author":"NC Chesnaye","year":"2022","unstructured":"Chesnaye NC, Stel VS, Tripepi G, et al. An introduction to inverse probability of treatment weighting in observational research. Clin Kidney J. 2022. https:\/\/doi.org\/10.1093\/ckj\/sfab158.","journal-title":"Clin Kidney J"},{"key":"860_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/biomet\/asn055","volume":"96","author":"RK Crump","year":"2009","unstructured":"Crump RK, Hotz VJ, Imbens GW, Mitnik OA. Dealing with limited overlap in estimation of average treatment effects. Biometrika. 2009;96:187\u201399. https:\/\/doi.org\/10.1093\/biomet\/asn055.","journal-title":"Biometrika"},{"key":"860_CR24","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/03610910902859574","volume":"38","author":"PC Austin","year":"2009","unstructured":"Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38:1228\u201334. https:\/\/doi.org\/10.1080\/03610910902859574.","journal-title":"Commun Stat Simul Comput"},{"key":"860_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108087","author":"A Gambardella","year":"2021","unstructured":"Gambardella A, Tinuper P, Acone B, et al. Selection of antiseizure medications for first add-on use: a consensus paper. Epilepsy Behav. 2021. https:\/\/doi.org\/10.1016\/j.yebeh.2021.108087.","journal-title":"Epilepsy Behav"},{"key":"860_CR26","doi-asserted-by":"publisher","unstructured":"Bonanni P, Gambardella A, Tinuper P, et al. Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements. BMC Neurol 2021. https:\/\/doi.org\/10.1186\/s12883-021-02450-y","DOI":"10.1186\/s12883-021-02450-y"},{"key":"860_CR27","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1528-1167.2010.02520.x","volume":"51","author":"MP Canevini","year":"2010","unstructured":"Canevini MP, De Sarro G, Galimberti CA, et al. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia. 2010;51:797\u2013804. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02520.x.","journal-title":"Epilepsia"},{"key":"860_CR28","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1111\/j.1528-1167.2011.03325.x","volume":"52","author":"C Luoni","year":"2011","unstructured":"Luoni C, Bisulli F, Canevini MP, et al. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia. 2011;52:2181\u201391. https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03325.x.","journal-title":"Epilepsia"},{"key":"860_CR29","doi-asserted-by":"publisher","first-page":"E239","DOI":"10.1212\/WNL.0000000000009880","volume":"95","author":"V Franco","year":"2020","unstructured":"Franco V, Canevini MP, De Sarro G, et al. Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial. Neurology. 2020;95:E239\u201346. https:\/\/doi.org\/10.1212\/WNL.0000000000009880.","journal-title":"Neurology"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00860-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-025-00860-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00860-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:51:48Z","timestamp":1768398708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-025-00860-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1007\/s40120-025-00860-5","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Roberta Roberti has received speaker\u2019s or consultancy fees from Eisai, UCB Pharma and Jazz Pharmaceuticals. Francesca Anzellotti has received travel support from Eisai, UCB and Angelini Pharma; and has speaker honoraria from Eisai and Angelini Pharma. Giovanni Boero has received speaker\u2019s or consultancy fees from Eisai, Angelini Pharma and UCB Pharma. Paolo Bonanni has received speaker\u2019s or consultancy fees from Bial, Eisai, GW, LivaNova, Lusofarmaco, Proveca and Roche. Laura Canafoglia has participated in pharmaceutical industry-sponsored clinical trials for UCB Pharma and other pharmaceutical industries; and has received speaker honoraria from Eisai. Alfredo D\u2019Aniello has participated in pharmaceutical industry-sponsored clinical trials for UCB Pharma; has received speaker honoraria and consultancy fees from Eisai, UCB Pharma, Angelini Pharma and Neuraxpharm; and has served on advisory boards for Angelini Pharma. Filippo Dainese has received speaker\u2019s or consultancy fees from UCB Pharma, Eisai and Bial. Giancarlo Di Gennaro has received speaker honoraria from UCB Pharma, Eisai, Lusofarmaco, Livanova, Angelini Pharma and Jazz Pharmaceuticals; and has served on advisory board for Bial, Arvelle, Angelini Pharma, Livanova, Neuraxpharma and UCB Pharma. Fedele Dono has received travel support from Eisai, UCB Pharma and Angelini Pharma; and has received speaker honoraria from Eisai. Giovanni Falcicchio has received speaker fees from Angelini Pharma. Edoardo Ferlazzo has received speaker honoraria from UCB Pharma, Eisai and Angelini Pharma. Antonio Gambardella has received speaker honoraria from UCB Pharma, Eisai, Angelini Pharma, Jazz, Bial and Zambon. Angela La Neve has received speaker\u2019s or consultancy fees from Eisai, Mylan, Sanofi, Bial, GW, Arvelle, Angelini Pharma and UCB Pharma; and has served on scientific advisory boards for GW Pharma, Jazz Pharmaceuticals and Angelini Pharma. Simona Lattanzi has received speaker\u2019s or consultancy fees from Angelini Pharma, Eisai, GW Pharmaceuticals, Medscape and UCB Pharma; and has served on advisory boards for Angelini Pharma, Arvelle Therapeutics, BIAL, Eisai and GW Pharmaceuticals outside the submitted work. Simona Lattanzi received research grant support from the Ministry of Health and the Ministry of University and Research outside the submitted work. Pietro Mattioli has received speaker honoraria from Angelini Pharma. Emilio Russo has received speaker fees or funding from and has participated on advisory boards for Angelini Pharma, Eisai, Ethypharm, GW Pharmaceuticals, Jazz Pharmaceuticals, Kolfarma and UCB Pharma. Simona Lattanzi is an Editorial Board member of\n                      Neurology and Therapy\n                      , but was not involved in the selection of peer reviewers for the manuscript or in any of the subsequent editorial decisions. Cristina Politi, Vincenzo Belcastro, Simone Beretta, Carmen De Caro, Roberta Di Giacomo, Jacopo C DiFrancesco, Nicoletta Foschi, Alfonso Giordano, Angelo Labate, Ugo Leggio, Claudio Liguori, Marta Maschio, Annacarmen Nilo, Francesca Felicia Operto, Angelo Pascarella, Giada Pauletto, Luciano Pellegrino, Rosaria Renna and Gionata Strigaro and Gianfranco Di Gennaro have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The overall, anonymized data collection was approved by the Ethics Committee of Calabria Region, Italy (protocol number 115\/19) and conducted in accordance with the Declaration of Helsinki. As the study was based on retrospective and fully anonymized data, written informed consent was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}